Stevanato Group S P A's Customers Performance

Name: Stevanato Group S P A Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

STVN

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


STVN's Source of Revenues		During the corresponding time, Stevanato Group S P A recorded a revenue increase by 7.45 % year on year, While revenue at the Stevanato Group S P A 's corporate clients • List of STVN Customers

for the same period Stevanato Group S P A recorded revenue increase by 7.45 % year on year,

• List of STVN Customers

Stevanato Group S P A's Business Units


Total Segments	111.39 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions	87.51 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions Customer	10.74 %	of total Revenue
External Customers	100 %	of total Revenue
Adjustments Eliminations and Unallocated Items	-10.1 %	of total Revenue
Adjustments Eliminations and Unallocated Items Inter-Segment	-11.39 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions External Customers	87.51 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions Inter-Segment	0.18 %	of total Revenue
Engineering	12.49 %	of total Revenue
Engineering External Customers	12.49 %	of total Revenue
Engineering Inter-Segment	11.2 %	of total Revenue
Total External Customers	100 %	of total Revenue
Total Inter-Segment	11.39 %	of total Revenue
High-Value Solutions	46.06 %	of total Revenue
Other Containment and Delivery Solutions	41.46 %	of total Revenue
Revenue from Engineering	12.49 %	of total Revenue
EMEA	58.19 %	of total Revenue
APAC	8.55 %	of total Revenue
North America	30.52 %	of total Revenue
South America	2.73 %	of total Revenue
Goods and Services Transferred at a Point in Time	87.27 %	of total Revenue
Goods and Services Transferred Over Time	12.73 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions High-Value Solutions	46.06 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions Other Containment and Delivery Solutions	41.46 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions EMEA	49.33 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions APAC	7.39 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions North America	28.27 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions South America	2.52 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions Goods and Services Transferred at a Point in Time	85.01 %	of total Revenue
Biopharmaceutical and Diagnostic Solutions Goods and Services Transferred Over Time	2.5 %	of total Revenue
Engineering Revenue from Engineering	12.49 %	of total Revenue
Engineering EMEA	8.86 %	of total Revenue
Engineering APAC	1.16 %	of total Revenue
Engineering North America	2.25 %	of total Revenue
Engineering South America	0.21 %	of total Revenue
Engineering Goods and Services Transferred at a Point in Time	2.26 %	of total Revenue
Engineering Goods and Services Transferred Over Time	10.23 %	of total Revenue
Italy	7.87 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Stevanato Group S P A's Comment on Sales, Marketing and Customers

The company provides drug containment, drug delivery, diagnostic, and engineering solutions to the pharmaceutical, biotechnology, and life sciences industries. Its integrated portfolio supports customer needs throughout the drug product life cycle, from development to clinical and commercial stages. As of 2024, the company has partnered with over 700 companies worldwide, including 23 of the top 25 pharmaceutical companies and six of the top ten in-vitro diagnostic companies. It has expanded internationally through acquisitions of Medical Glass, Optrel, Innoscan, Balda, Medirio, SVM Automatik, and Perugini S.r.l., as well as through organic growth with new manufacturing sites in Mexico, China, Brazil, and the United States. The company prioritizes maintaining manufacturing capacity to meet customer demand and invests in new facilities and expansions.

News about Stevanato Group S p a Contracts

Stevanato Group, Gerresheimer, and SCHOTT Pharma Forge Strategic Alliance to Propel Ready-to-Use Solution...

Piombino Dese, Italy In a significant development for the pharmaceutical, biotechnology, and life sciences sectors, Stevanato Group S.p.A. (NYSE: STVN), a leading global provider in drug containment, delivery, and diagnostic solutions, has announced a strategic alliance with Gerresheimer AG (MDAX: GXI) and SCHOTT Pharma AG and Co. KGaA (MDAX: 1SXP). This collaboration, termed the Alliance for RTU (Ready-to-Use), aims to accelerate the market adoption of RTU vials and cartridges an innovation poised to streamline drug manufacturing and improve product quality.This joint initiative brings together three industry leaders combining their expertise to enhance efficiency and facilitate the rapid deployment of R...

Stevanato Group S P A’s Comment on Sales, Marketing and Customers

STVN's Stock Performance relative to it's Customers

STVN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Stevanato Group S p a	5,950.51	1,328.64	156.61	6,010
SUBTOTAL	0.00	0.00	0.00	-

Sources: Stevanato Group S p a’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Stevanato Group S p a’s corporate clients.
For your research, we’ve provided 9 tables on Stevanato Group S p a corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.